Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

BioTelemetry Inc

+ Add to Watchlist

C25:GR

8.116 EUR 0.038 0.47%

As of 10:10:35 ET on 04/24/2015.

Snapshot for BioTelemetry Inc (C25)

Open: 8.037 Day's Range: 7.989 - 8.116 Volume: 0
Previous Close: 8.154 52wk Range: 4.740 - 9.759 1-Yr Rtn: +31.16%

Stock Chart for C25

No chart data available.
  • C25:GR 7.989
  • 1D
  • 1M
  • 1Y
8.154
Interactive C25 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for C25

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 23.8062
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 0.3700
Est. PEG Ratio 0.7935
Market Cap (M EUR) 218.55
Shares Outstanding (M) 26.93
30 Day Average Volume 13
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for C25

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for C25

BioTelemetry, Inc. provides ambulatory outpatient management solutions for monitoring clinical information regarding an individual's health. The Company's initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders.

Joseph H Capper "Joe"President/CEOHeather C GetzSenior VP/CFO
Michael D GeldartSenior VP:Bus Dev/COOPeter FerolaSenior VP:Corporate Dev/Secy
More Company Profile & Key Executives for C25

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil